×
News Home

Pacific Biosciences of California Inc (PACB) Up 2.15% in Premarket Trading

Monday, August 08, 2022 09:07 AM | InvestorsObserver Analysts
Pacific Biosciences of California Inc (PACB) Up 2.15% in Premarket Trading

Pacific Biosciences of California Inc (PACB) is higher by Monday morning, with the stock gaining 2.15% in pre-market trading to 6.19. PACB's short-term technical score of 7 indicates that the stock has traded less bullishly over the last month than 93% of stocks on the market. In the Medical Devices industry, which ranks 134 out of 146 industries, the stock ranks higher than 15% of stocks. Pacific Biosciences of California Inc has risen 11.19% over the past month, closing at $4.88 on July 11. During this period of time, the stock fell as low as $3.93 and as high as $6.37. PACB has an average analyst recommendation of Buy. The company has an average price target of $18.83.

Overall Score - 38
PACB has an Overall Score of 38. Find out what this means to you and get the rest of the rankings on PACB!
Pacific Biosciences of California Inc has a Long-Term Technical rank of 12. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 88% of the market scoring higher. In the Medical Devices industry which is number 77 by this metric, PACB ranks better than 77% of stocks.

Important Dates for Investors in PACB:

-Pacific Biosciences of California Inc is set to release earnings on 11/1/2022. Over the last 12 months, the company has reported EPS of $-0.94. -We do not have a set dividend date for Pacific Biosciences of California Inc at this time. Click Here To Get The Full Report on Pacific Biosciences of California Inc (PACB)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App